Herbal Monograph
Yellow Dock
Rumex crispus L.
Polygonaceae (Buckwheat family)
Classic alterative root for chronic skin conditions, gentle iron-rich laxative, and liver support
Overview
Plant Description
Yellow Dock is a robust, erect herbaceous perennial growing 60-120 cm (2-4 feet) tall from a stout, fleshy, yellow-brown taproot that can reach 20-30 cm (8-12 inches) in length and 2-3 cm in diameter. The root bark is dark reddish-brown externally, revealing a bright yellow to orange-yellow interior when sliced -- the color from which the common name derives. The stem is erect, grooved, branching in the upper portions, and somewhat reddish at maturity. Basal leaves are large (15-30 cm long), lanceolate to oblong-lanceolate, with characteristically wavy, crisped (curled) margins that give the plant both its species name ('crispus' meaning curled) and the common name Curly Dock. Upper stem leaves are progressively smaller and more narrow. Flowers are small, green to reddish-green, borne in dense, elongated terminal panicles (racemes) that become conspicuously russet-brown at maturity. Each flower produces a three-valved, heart-shaped fruit (achene) enclosed in enlarged inner tepals (valves), each valve bearing a characteristic rounded, grain-like callosity (tubercle) on its surface -- an important identification feature. The plant has a membranous sheath (ocrea) surrounding the stem at each node, characteristic of the Polygonaceae family. Yellow Dock is easily recognized by the combination of curly-margined leaves, dense rusty-brown fruiting panicles, and the bright yellow root interior.
Habitat
Yellow Dock thrives in disturbed, nutrient-rich soils and is a common ruderal plant of roadsides, field edges, waste ground, pastures, ditches, riverbanks, and cultivated ground. It tolerates a wide range of soil types but prefers moderately fertile, moist to somewhat heavy soils. It is particularly abundant in clay and loam soils with good moisture retention. The plant is drought-tolerant once established due to its deep taproot. It is considered a serious agricultural weed in many regions, especially in grasslands, cereals, and row crops. The species is shade-intolerant and favors open, sunny locations. It is highly tolerant of soil compaction and moderate salinity.
Distribution
Rumex crispus is native to Europe, western Asia, and North Africa. It has become naturalized worldwide and is now one of the five most widely distributed plant species on Earth, found on every continent except Antarctica. It was introduced to North America in the colonial era (likely as a contaminant in crop seed and ship ballast) and is now thoroughly established across the United States, Canada, and Mexico. It is equally abundant across Australia, New Zealand, South America, southern Africa, and temperate to subtropical Asia. In many regions it is classified as an invasive weed. Its cosmopolitan distribution has made it one of the most universally available medicinal plants in Western herbalism.
Parts Used
Root (Radix Rumicis Crispi)
Preferred: Dried sliced root for decoction; tincture of fresh or dried root (1:5 in 40% ethanol); standardized root extract capsules
The dried root is the official drug in the British Herbal Pharmacopoeia (BHP 1983) and the primary part used in Western herbal practice. The root contains the highest concentration of anthraquinone glycosides, tannins, and bioavailable iron -- the three constituent classes most responsible for Yellow Dock's therapeutic activity. The bright yellow to orange-yellow internal color of the fresh root (due to anthraquinone pigments) is a quality indicator. Second- or third-year autumn-harvested roots are preferred for maximum potency. The root is extremely dense and requires decoction rather than simple infusion for adequate extraction.
Leaf (young spring leaves)
Preferred: Cooked as a potherb (boil and discard first water to reduce oxalates); fresh leaf poultice for topical use
Young spring leaves have been used as a potherb and nutritive food plant across multiple cultures. Rich in vitamins A and C, iron, and minerals. Contains significant oxalic acid (as with other Rumex and related Polygonaceae species) which is reduced by cooking. The leaves have mild laxative and nutritive properties but are considered secondary to the root for formal therapeutic use. Some traditional practices use leaf poultices topically for skin conditions.
Key Constituents
Anthraquinone glycosides (hydroxyanthracene derivatives)
The anthraquinone glycosides are responsible for Yellow Dock's mild laxative action and contribute significantly to its alterative properties. The total anthraquinone content of R. crispus root (approximately 0.2-1.0% total hydroxyanthracene derivatives) is substantially lower than that of official laxative drugs such as senna leaf (1.5-3.0% sennosides) or cascara bark (6-9% cascarosides). This low concentration means Yellow Dock acts as a gentle bowel stimulant that promotes regular elimination without the griping, urgency, or dependency associated with stronger anthraquinone laxatives. In Eclectic and alterative theory, this gentle promotion of elimination is considered essential to the 'blood-cleansing' action -- by ensuring efficient waste removal through the bowel and stimulating bile flow, the body's eliminative capacity is enhanced. The anthraquinone glycosides require bacterial hydrolysis in the colon for activation, meaning the laxative effect is delayed (6-12 hours after ingestion) and acts specifically on the large intestine.
Tannins
The tannin content is therapeutically significant in two ways. First, the astringent action on gastrointestinal mucosa provides a toning, anti-inflammatory effect on the bowel wall, making Yellow Dock suitable for conditions with loose stools or intestinal inflammation rather than being purely cathartic. This is why Yellow Dock was described by Eclectic physicians as appropriate for both constipation and diarrhea -- the tannins tone lax tissue while the anthraquinones gently stimulate sluggish peristalsis. Second, topically, the tannin content provides the basis for Yellow Dock's traditional use as a wound-healing and anti-inflammatory agent for skin conditions. Tannins precipitate surface proteins, reduce weeping, and create an inhospitable environment for microbial colonization.
Minerals (bioavailable iron and other elements)
The iron content of Yellow Dock root is central to its traditional reputation as a 'blood builder' and alterative. In Eclectic and traditional Western herbal medicine, Yellow Dock is one of the primary botanical sources of supplemental iron, used for iron-deficiency anemia, chlorosis (the historical term for iron-deficiency in young women), and general debility associated with poor nutritional status. The organic form of iron in the plant is generally better tolerated than pharmaceutical ferrous sulfate, causing less constipation and gastrointestinal irritation. The synergy between iron delivery and enhanced absorption (via cholagogue action) and prevention of iron-related constipation (via mild laxative effect) makes Yellow Dock a uniquely well-suited botanical iron source.
Oxalates
The oxalate content is primarily a safety consideration rather than a therapeutic one. At standard therapeutic doses of the root (decoction or tincture), the oxalate intake is modest and generally not clinically problematic. However, the presence of oxalates is the basis for the standard contraindication in individuals with a history of calcium oxalate kidney stones. The leaves contain substantially more oxalate than the root, which is why the root is preferred for therapeutic use. Cooking the leaves as a potherb (and discarding the cooking water) substantially reduces oxalate exposure.
Volatile oil and miscellaneous constituents
These miscellaneous constituents contribute to the overall therapeutic profile of Yellow Dock in secondary and supportive roles. Rumicin, as described in Eclectic literature, appears to represent the combined activity of anthraquinone derivatives. The organic acids play a role in iron chelation and bioavailability. The trace volatile oil and mucilage contribute to gastrointestinal tolerability.
Herbal Actions
Gradually restores proper body function and increases overall health
Yellow Dock is one of the most highly regarded alterative herbs in Western herbal medicine, particularly in the Eclectic tradition. The alterative action describes the herb's ability to gradually restore proper function and improve overall health, traditionally described as 'blood cleansing' or 'depurative' activity. The mechanism is understood as a combination of: (1) enhanced hepatobiliary function (cholagogue action promoting bile flow and liver detoxification), (2) gentle promotion of bowel elimination (mild laxative action ensuring efficient waste removal), (3) iron supplementation and improved nutritional status, and (4) astringent toning of the gastrointestinal mucosa. This multi-system support of the body's eliminative and nutritive functions underlies Yellow Dock's traditional use for chronic skin conditions, anemia, and sluggish digestion. King's American Dispensatory (Felter & Lloyd) describes Yellow Dock as 'one of the most useful remedies among the alteratives.'
[1, 2, 9]Stimulates bile flow from the gallbladder
Yellow Dock root is a significant cholagogue, stimulating the flow of bile from the gallbladder and promoting bile production by the liver. This action is attributed primarily to the bitter principles (anthraquinones and related compounds) that stimulate bitter taste receptors and trigger the vagal reflex promoting bile secretion. Enhanced bile flow supports fat digestion and absorption of fat-soluble nutrients, promotes the excretion of metabolic waste products and conjugated toxins through the bile, and has a gentle laxative effect (bile salts act as natural laxatives in the colon). The cholagogue action is central to Yellow Dock's alterative mechanism -- by promoting hepatobiliary clearance, the herb supports the liver's role as the primary organ of detoxification. The British Herbal Pharmacopoeia specifically lists the cholagogue action.
[1, 2, 9]Promotes bowel movement
Yellow Dock provides a mild, gentle laxative action attributable to its anthraquinone glycosides (emodin, chrysophanol, physcion). The anthraquinone content is considerably lower than in official laxative herbs such as senna (Cassia spp.) or cascara (Rhamnus purshiana), making Yellow Dock a gentle bowel regulator rather than a strong cathartic. The laxative effect is further moderated by the significant tannin content, which provides an astringent, toning counter-action on the bowel wall. This balanced combination makes Yellow Dock particularly suited for chronic, atonic constipation where the bowel needs both stimulation and toning, rather than acute constipation requiring strong catharsis. The BHP (1983) classifies the laxative action as secondary to the alterative and cholagogue activities. Onset of action is typically 6-12 hours after ingestion, consistent with the requirement for colonic bacterial hydrolysis of anthraquinone glycosides.
[1, 2, 10]Tightens and tones tissue, reduces secretions
The substantial tannin content (5-10% condensed tannins) provides a significant astringent action. Tannins bind to and precipitate proteins on mucosal surfaces, forming a protective, anti-inflammatory layer that tones lax tissue and reduces excessive secretion. This astringent action is expressed both internally (toning the gastrointestinal mucosa) and topically (when Yellow Dock preparations are applied to the skin). Internally, the astringency counterbalances the laxative anthraquinones, producing a preparation that tones and stimulates simultaneously. Topically, the tannins contribute to Yellow Dock's traditional use for weeping eczema, minor wounds, and hemorrhoids.
[1, 2]Stimulates digestive secretions via bitter taste receptors
Yellow Dock root is noticeably bitter, a property attributed primarily to the anthraquinone glycosides and related compounds. The bitter taste stimulates digestive secretions via bitter taste receptors (T2R family) on the tongue and throughout the gastrointestinal tract, triggering vagally mediated increases in saliva, gastric acid, pancreatic enzyme, and bile secretion. This bitter tonic action enhances overall digestive efficiency and is synergistic with the cholagogue activity. The Eclectics valued Yellow Dock as a digestive bitter particularly indicated in cases of sluggish digestion associated with hepatic torpor.
[1, 9]Reduces inflammation
Anti-inflammatory activity has been demonstrated in preclinical studies for several Yellow Dock constituents, including emodin (inhibition of NF-kB, COX-2, and pro-inflammatory cytokines in vitro), chrysophanol, and the tannin fraction. The anti-inflammatory action contributes to Yellow Dock's traditional use in inflammatory skin conditions and gastrointestinal inflammation, though this action is considered mild and supportive rather than a primary indication for the herb.
[1, 5]Kills or inhibits the growth of microorganisms
Yellow Dock root demonstrates moderate antimicrobial activity, particularly antifungal activity. Chrysophanol and nepodin have shown in vitro activity against dermatophyte fungi (Trichophyton, Microsporum, Epidermophyton species), providing a pharmacological basis for the traditional topical use of Yellow Dock in ringworm and other fungal skin infections. Antibacterial activity against Staphylococcus aureus and other gram-positive organisms has also been reported. The tannin fraction contributes additional antimicrobial activity through protein precipitation and iron-binding mechanisms that deprive microorganisms of essential nutrients.
[5, 7]Therapeutic Indications
Skin / Integumentary
Chronic eczema (atopic dermatitis) with weeping or crusting lesions
One of Yellow Dock's most valued traditional indications. The Eclectic physicians considered it specific for chronic, obstinate eczema associated with hepatic congestion and poor eliminative function. The combined alterative, cholagogue, and astringent actions address both the internal (hepatobiliary, eliminative) and external (inflammatory, weeping) components of the condition. Used internally as decoction or tincture and/or topically as a wash or ointment. The BHP (1983) specifically lists eczema as an indication.
[1, 2, 9]Psoriasis
Yellow Dock has a long history of use for psoriasis in Eclectic and British herbal traditions. The presence of chrysarobin (historically used pharmaceutically for psoriasis as an active constituent of Goa powder) and the anthraquinone emodin provide some pharmacological rationale. The alterative approach -- addressing hepatic function, elimination, and systemic inflammation rather than targeting the skin lesion directly -- is characteristic of traditional herbal management of psoriasis. Typically used as part of a broader alterative formula over months rather than as a standalone remedy.
[1, 9, 10]Acne and boils (furunculosis)
Traditional use as an internal alterative for chronic, recurrent acne and boils, understood as reflecting impaired eliminative function and 'blood impurity.' The alterative and cholagogue actions are believed to improve the body's handling of metabolic waste products, reducing the burden that manifests as skin eruptions. Particularly indicated when acne is associated with sluggish digestion and constipation.
[1, 9]Ringworm and fungal skin infections (dermatophytosis)
Topical application of Yellow Dock root decoction or tincture for ringworm (tinea corporis, tinea capitis) is well documented in Eclectic and folk traditions. Chrysophanol and nepodin demonstrate in vitro antifungal activity against dermatophytes. The tannin content provides additional antimicrobial and astringent support. Both internal and topical use are traditional.
[5, 9, 11]Urticaria (nettle rash, hives)
The fresh leaves of Rumex species have a widespread folk reputation as an antidote to nettle stings (Urtica dioica), applied as a poultice directly to the affected area. The root decoction or tincture is used internally for chronic urticaria as part of an alterative protocol. The tannins may provide a local soothing, anti-inflammatory effect when applied topically.
[4, 11]Digestive System
Chronic constipation (atonic type)
Yellow Dock is specifically indicated for chronic, habitual constipation of the atonic type -- where the bowel lacks tone and peristaltic drive rather than being obstructed or spastic. The combination of mild anthraquinone laxative action with astringent tannin toning makes it uniquely suited for this pattern. It promotes regular elimination without the griping, dependency, or electrolyte depletion associated with stronger anthraquinone laxatives. The BHP (1983) lists constipation as a primary indication. Typically used over weeks to months to restore normal bowel function rather than as an acute laxative.
[1, 2, 9]Sluggish digestion with hepatic torpor
The bitter tonic and cholagogue actions make Yellow Dock valuable for sluggish digestion associated with inadequate bile flow and hepatic congestion. Symptoms may include heavy feeling after eating, poor fat digestion, bloating, and a coated tongue. The Eclectics described Yellow Dock as specific for the 'torpid liver' constitution with poor appetite, constipation, and sallow complexion.
[9, 10]Upper gastrointestinal inflammation (gastritis, esophagitis)
The tannin and mucilage content provide an astringent, mildly protective effect on the upper GI mucosa. Some practitioners use small doses of Yellow Dock tincture or decoction for mild gastritis and acid reflux, relying on the astringent tightening of the lower esophageal sphincter and the protective tannin layer on inflamed mucosa. This is a secondary use, typically in combination with demulcent herbs.
[1]Hepatobiliary System
Hepatic congestion and sluggish liver function
Yellow Dock's cholagogue action makes it a primary herb for what traditional herbalists describe as 'liver congestion' or 'hepatic torpor' -- a functional pattern of impaired bile flow and hepatic clearance manifesting as sluggish digestion, constipation, fatigue, sallow complexion, and chronic skin problems. Yellow Dock stimulates both bile production (choleretic) and bile release (cholagogue), enhancing the liver's eliminative capacity. This hepatobiliary support is considered the cornerstone of Yellow Dock's alterative mechanism.
[1, 2, 9]Jaundice (mild, functional -- adjunctive use only)
Historical use for mild jaundice, reflecting the cholagogue action. Felter & Lloyd note Yellow Dock for jaundice associated with hepatic torpor. This indication is understood in modern practice as applicable only to mild, functional biliary sluggishness and NOT to obstructive jaundice, gallstone obstruction, or serious hepatobiliary disease, which require medical investigation and management.
[4, 9]Cardiovascular System
Iron-deficiency anemia
One of Yellow Dock's most important traditional indications and a use that remains central in modern Western herbal practice. The root provides bioavailable organic iron in a matrix that simultaneously enhances iron absorption (via cholagogue action improving fat-soluble nutrient uptake and bitter stimulation of digestive secretions) and prevents the constipation commonly caused by pharmaceutical iron supplements (via mild laxative action). Yellow Dock is a cornerstone ingredient in traditional 'blood-building' formulas, often combined with nettle leaf (Urtica dioica), dandelion root (Taraxacum officinale), and blackstrap molasses. While no modern RCTs have specifically evaluated Yellow Dock for anemia, the combination of meaningful iron content with absorption-enhancing and bowel-supporting actions represents a compelling traditional rationale that is consistent with modern nutritional science.
[1, 2, 9, 10]Lymphatic System
Lymphatic congestion and swollen glands
The alterative action of Yellow Dock extends to the lymphatic system in traditional understanding. Eclectic physicians used Yellow Dock for swollen lymph glands, scrofula (tubercular cervical lymphadenitis -- a historical indication), and general lymphatic congestion. The mechanism is understood as improved systemic elimination reducing the burden on the lymphatic system. This use is part of the broader alterative paradigm rather than a direct lymphatic action.
[9, 10]Reproductive System
Menorrhagia (heavy menstrual bleeding) -- adjunctive, iron replacement
Yellow Dock is used in traditional practice as an iron-replenishing herb for women with heavy menstrual periods leading to iron depletion. The astringent tannin content may also contribute a mild hemostatic effect. This is primarily a nutritive/supportive indication rather than a treatment for the underlying cause of menorrhagia. Typically combined with other iron-rich and hemostatic herbs (nettle, shepherd's purse, raspberry leaf).
[1, 10]Respiratory System
Chronic upper respiratory catarrh
The astringent tannin content and alterative action provide the basis for Yellow Dock's occasional use in chronic nasal and sinus catarrh with excessive mucus production. The drying, astringent quality addresses the tissue state of damp relaxation in the mucous membranes. This is a minor indication, typically addressed as part of a broader alterative formula rather than as a primary respiratory remedy.
[10]Energetics
Temperature
cool
Moisture
dry
Taste
Tissue States
damp/stagnation, damp/relaxation, hot/excitation
Yellow Dock is energetically cooling and drying -- characteristics that align with its bitter, astringent taste profile and its affinity for conditions of excess dampness, hepatic stagnation, and heat-related skin eruptions. The cooling quality makes it indicated for hot, inflamed, weeping skin conditions (eczema, psoriasis with redness and inflammation). The drying, astringent quality addresses tissue laxity and excessive secretion. The bitter quality stimulates and decongests sluggish hepatobiliary function. In Physiomedicalist terms, Yellow Dock is a stimulating alterative that moves stagnant processes and promotes elimination. Matthew Wood describes Yellow Dock as indicated for the 'congested, torpid' constitution with sluggish liver, poor iron absorption, and skin manifestations of internal congestion. It is best suited for robust or moderately robust constitutions and is less appropriate for very cold, dry, deficient individuals.
Traditional Uses
Eclectic American Medicine
- Primary alterative for chronic skin diseases (eczema, psoriasis, acne, boils, scrofulous conditions)
- Iron-deficiency anemia and chlorosis ('green sickness' in young women)
- Chronic constipation with hepatic torpor
- Jaundice and sluggish biliary function
- Scrofula and lymphatic congestion
- Chronic syphilitic skin eruptions (historical; in combination formulas)
- Scorbutic conditions (related to nutritional deficiency)
"Rumex is one of the most useful remedies among the alteratives. It is especially adapted to those cases of skin disease in which there is a want of activity of the liver and an absence of bile from the intestinal canal. The remedy acts upon the liver, promoting the secretion and flow of bile, and through its action upon the bowels, serves as a gentle laxative. It is particularly useful in those forms of chronic disease which depend upon a depraved condition of the blood."
[9]
Native American (multiple tribes)
- Root decoction as a blood purifier and general tonic (Cherokee, Iroquois, Chippewa)
- Root poultice or wash for sores, boils, and skin eruptions (Cherokee, Menominee)
- Root decoction for liver and gallbladder complaints (Iroquois)
- Root tea for 'bad blood' and venereal diseases (Cherokee)
- Leaf poultice applied to nettle stings and insect bites (widespread)
- Young leaves cooked as a spring potherb and nutritive food (multiple tribes)
- Root decoction as a wash for ringworm and itchy skin (Ojibwa, Potawatomi)
- Root infusion for diarrhea and dysentery (Meskwaki)
"Daniel Moerman's Native American Ethnobotany database records medicinal uses of Rumex crispus by at least 15 Native American tribes, including Cherokee, Iroquois, Chippewa, Menominee, Ojibwa, Meskwaki, and Potawatomi. Uses consistently center on blood purification, skin conditions, liver support, and the root as a nutritive tonic."
[11]
British Herbal Medicine
- Chronic skin diseases, especially eczema and psoriasis (BHP specific indication)
- Obstructive jaundice and constipation
- Mild laxative for habitual constipation
- Iron-deficiency anemia (as iron-containing nutritive)
- Cholagogue for biliary insufficiency
"The British Herbal Pharmacopoeia (1983) lists Rumex crispus root with specific indications for chronic skin disease, especially psoriasis associated with constipation. Actions listed: gentle laxative, alterative, cholagogue. Part used: root."
[2]
European Folk Medicine
- Root decoction as a spring tonic and blood cleanser (widespread across northern Europe)
- Topical application of fresh root juice or decoction for ringworm and scabies
- Young leaves as a spring vegetable and anti-scorbutic (scurvy prevention)
- Root poultice for boils, abscesses, and tumors
- Leaf poultice as an antidote to nettle stings (one of the most widespread plant remedies in European folk tradition)
- Root decoction for jaundice and liver complaints
- Dock leaf wrapped around butter to keep it fresh (astringent/antimicrobial folk use)
"Mrs. Grieve in A Modern Herbal (1931) notes: 'The Yellow Dock is applicable to all diseases connected with an impure condition of the blood; it is an excellent blood cleanser, and is of great value in the treatment of most skin diseases.' Grieve describes the widespread British folk custom of applying dock leaves to nettle stings."
[4]
Physiomedicalist Tradition
- Stimulating alterative for chronic, torpid conditions with skin manifestation
- Hepatic stimulant for sluggish liver with constipation and skin disease
- Blood depurative for 'strumous' (scrofulous) constitutions
- Gentle laxative that tones while it stimulates the bowel
"Priest & Priest (1982) in Herbal Medication classify Rumex crispus as a 'stimulating alterative' with specific action on the liver and bowels, indicated for 'chronic skin disease associated with gastro-intestinal and hepatic dysfunction.' They note its unique combination of laxative stimulation with astringent toning."
[10]
Modern Research
Antioxidant and free radical scavenging activity
Several in vitro studies have evaluated the antioxidant capacity of Rumex crispus root and leaf extracts. Methanol and aqueous extracts demonstrate significant DPPH, ABTS, and hydroxyl radical scavenging activity, attributed primarily to the phenolic content (tannins, anthraquinones, and flavonoids). The antioxidant activity provides a partial mechanistic basis for the traditional alterative and anti-inflammatory uses.
Findings: R. crispus root extracts showed dose-dependent antioxidant activity in multiple in vitro assays. Methanol extracts generally showed higher activity than aqueous extracts, consistent with the presence of both water-soluble (tannins) and lipophilic (anthraquinones) antioxidant compounds. Total phenolic content correlated with antioxidant capacity.
Limitations: In vitro antioxidant assays do not directly translate to in vivo efficacy. Bioavailability of anthraquinones and tannins after oral administration is variable. No clinical studies have evaluated the antioxidant effects of Yellow Dock in human subjects.
Antimicrobial activity of Rumex crispus extracts
In vitro studies have examined the antimicrobial activity of R. crispus root and leaf extracts against a panel of bacteria and fungi. The extracts demonstrate moderate antibacterial activity (particularly against Gram-positive organisms including Staphylococcus aureus) and notable antifungal activity against dermatophytes. These findings provide pharmacological support for the traditional topical use in skin infections.
Findings: Methanol and ethanol root extracts showed inhibition zones against Staphylococcus aureus, Bacillus subtilis, and Escherichia coli at concentrations of 50-200 mg/mL. Antifungal activity was demonstrated against Candida albicans and Trichophyton species. Chrysophanol and nepodin were identified as key antimicrobial constituents. Activity was generally moderate compared to pharmaceutical antimicrobials.
Limitations: In vitro disk diffusion and MIC studies using crude extracts at relatively high concentrations. Clinical relevance of these findings is uncertain. No controlled clinical trials of Yellow Dock as an antimicrobial agent have been published.
Anti-inflammatory activity of emodin and related anthraquinones
Emodin, the principal anthraquinone of Yellow Dock, has been extensively studied for anti-inflammatory activity in preclinical models. Studies demonstrate inhibition of NF-kB signaling, COX-2 expression, TNF-alpha, IL-1beta, and IL-6 production in multiple cell types. These studies primarily use purified emodin rather than whole Yellow Dock extracts, but provide a pharmacological basis for the anti-inflammatory component of Yellow Dock's alterative action.
Findings: Emodin inhibited LPS-induced NF-kB activation and reduced pro-inflammatory cytokine production (TNF-alpha, IL-1beta, IL-6) in macrophage cell lines. Emodin also inhibited COX-2 protein expression and PGE2 production. In animal models, emodin showed anti-inflammatory effects in carrageenan-induced paw edema and other acute inflammation models. IC50 values for NF-kB inhibition ranged from 10-50 micromolar depending on cell type.
Limitations: Studies used purified emodin, not whole Yellow Dock extracts. Emodin bioavailability after oral administration is limited (extensive first-pass metabolism and glucuronidation). Concentrations achieving anti-inflammatory effects in vitro may not be achievable systemically from Yellow Dock root doses. The anti-inflammatory effects are well-documented for emodin as a compound but extrapolation to Yellow Dock root as a whole herb preparation requires caution.
[8]
Iron content and bioavailability assessment
Analytical studies have confirmed significant iron content in R. crispus root, supporting its traditional use as a botanical iron source. The iron is present in organic chelated forms believed to have superior bioavailability compared to inorganic iron salts, though direct comparative bioavailability studies in humans are lacking.
Findings: Chemical analyses confirm iron content of approximately 0.7-1.2 mg per gram of dried root, though values vary substantially with soil conditions and geographic origin. The iron is associated with organic acid complexes (citrate, malate, oxalate) that may facilitate absorption. A standard decoction of Yellow Dock root (2-4 g dried root in 250 mL water) could provide 1.4-4.8 mg of iron per dose. Combined with the cholagogue and digestive-stimulant actions that enhance absorption, this represents a meaningful contribution to daily iron intake (RDA: 8-18 mg/day).
Limitations: No controlled human studies directly comparing Yellow Dock iron absorption with pharmaceutical iron supplements have been published. The total iron content per dose is modest compared to pharmaceutical iron tablets (65-200 mg elemental iron). The traditional evidence for efficacy in anemia is strong but not validated by modern RCTs. The oxalate content may partially offset iron bioavailability, though the organic acid matrix may counteract this.
Cytotoxic and antiproliferative activity
Preliminary in vitro studies have investigated the cytotoxic activity of R. crispus extracts and individual anthraquinone constituents against cancer cell lines. Emodin in particular has demonstrated antiproliferative, pro-apoptotic, and anti-metastatic effects in multiple cancer cell models, though these studies used purified compounds at concentrations unlikely achievable from dietary use of Yellow Dock.
Findings: Ethanol and methanol extracts of R. crispus root showed cytotoxic activity against several human cancer cell lines (breast, colon, lung, liver) in MTT assays, with IC50 values ranging from 50-500 micrograms/mL. Emodin specifically induced apoptosis via caspase activation and mitochondrial pathway in various cancer cell lines. Chrysophanol showed antiproliferative effects on hepatocellular carcinoma cells. Whole root extracts showed lower potency than purified compounds.
Limitations: All studies were in vitro. The concentrations of emodin achieving anticancer effects in vitro (typically 10-100 micromolar) are unlikely to be achieved systemically from oral Yellow Dock administration due to low total anthraquinone content and limited bioavailability. No clinical or animal studies have specifically evaluated Yellow Dock for cancer. These findings should not be interpreted as evidence that Yellow Dock treats cancer.
[6]
Wound-healing and dermatological activity
Limited preclinical research has examined the wound-healing and skin-active properties of R. crispus extracts. The tannin fraction demonstrates protein-precipitating, anti-inflammatory, and antimicrobial properties relevant to wound healing. Emodin and chrysarobin have known dermatological activity (chrysarobin was historically a key antipsoriatic agent).
Findings: In a rodent wound-healing model, topical application of R. crispus root extract ointment (5% and 10%) promoted wound contraction and epithelialization compared to untreated controls. The 10% extract showed wound-healing rates comparable to the positive control. Histological examination showed enhanced collagen deposition and reduced inflammatory infiltrate in treated wounds. The tannin-rich fraction was identified as the primary contributor to wound-healing activity.
Limitations: Limited number of preclinical studies. Animal wound-healing models have variable translation to human clinical outcomes. No human clinical trials for any dermatological application of Yellow Dock. The traditional dermatological uses, while extensive, remain supported primarily by historical clinical observation rather than controlled studies.
[6]
Preparations & Dosage
Decoction
Strength: 2-4 g dried root per 250 mL water
Place 2-4 grams (approximately 1-2 teaspoons) of dried, sliced Yellow Dock root in 250-300 mL of cold water. Bring to a gentle boil, then reduce heat and simmer covered for 10-15 minutes. Strain. The resulting decoction will be reddish-brown to amber in color with a distinctly bitter, astringent taste. Decoction is the preferred method for the dense, woody root, as simple infusion does not adequately extract the active constituents.
1 cup (250 mL) of decoction two to three times daily
Two to three times daily, typically taken 20-30 minutes before meals to maximize cholagogue and bitter tonic effects
For chronic alterative indications (skin conditions, anemia), use for 6-12 weeks as a course of treatment. For constipation, use for 2-4 weeks to re-establish bowel regularity, then taper. Not intended for continuous long-term use beyond 3 months without reassessment.
Not generally recommended for children under 12; if used, one-quarter to one-half adult dose for children 6-12 under practitioner supervision
Decoction is the traditional and preferred aqueous preparation due to the dense, fibrous nature of the root. Simmering is necessary to extract the anthraquinones, tannins, and iron. The decoction may be sweetened with honey or combined with licorice root to improve palatability. For iron-deficiency anemia, some practitioners recommend cooking the decoction in an iron pot to further increase iron content, a practice documented in folk tradition. The decoction is stable for 48-72 hours when refrigerated.
Tincture
Strength: 1:5 in 40% ethanol (dried root); 1:2 in 50% ethanol (fresh root)
Prepare using dried Yellow Dock root chopped or coarsely ground, macerated in 40% ethanol (vodka or grain alcohol diluted to 40% ABV) at a 1:5 ratio by weight. Macerate for 2-4 weeks in a sealed glass jar, shaking daily. Strain through muslin cloth and press the marc to extract residual liquid. Store in amber glass bottles. Alternatively, a fresh root tincture may be prepared at 1:2 in 50% ethanol when fresh autumn-harvested root is available.
2-4 mL (approximately 40-80 drops or 1/2 to 1 teaspoon) three times daily
Three times daily, ideally 15-30 minutes before meals
For chronic conditions: 6-12 week courses with 2-week breaks. For digestive support: ongoing use at lower doses (1-2 mL twice daily) is acceptable for longer periods.
Not generally recommended for children under 12; if used under practitioner guidance, 0.5-1 mL (10-20 drops) for children 6-12
Tincture is the most convenient and commonly used preparation in modern Western herbal practice. The hydroalcoholic menstruum extracts both the water-soluble tannins and the less water-soluble anthraquinones, providing a more complete extraction than aqueous decoction alone. The BHP (1983) specifies the 1:5 / 40% ethanol preparation. The tincture has a deep reddish-brown color and a strongly bitter, astringent taste. It may be taken in water, juice, or combined with other tinctures in formula.
Capsule / Powder
Strength: Powdered whole root or 4:1 to 10:1 concentrated extract (follow manufacturer's dosing)
Fill size 00 gelatin or vegetable capsules with finely powdered dried Yellow Dock root. Alternatively, commercial encapsulated products are available, sometimes as standardized extracts (standardized to anthraquinone or emodin content).
1-2 grams (approximately 2-4 size 00 capsules) of powdered root two to three times daily, or as directed on commercial product labels
Two to three times daily with meals
6-12 week courses for alterative indications; 2-4 weeks for constipation
Not recommended for children under 12
Capsules are useful for individuals who find the bitter taste of the decoction or tincture unacceptable. However, some practitioners argue that the bitter taste itself is therapeutically important (triggering cephalic-phase digestive responses via bitter taste receptors), and that bypassing this with capsules diminishes the bitter tonic and cholagogue effects. For purely nutritive/iron-supplementing purposes, capsules are acceptable. For digestive and cholagogue indications, liquid preparations (tincture or decoction) are preferred.
[1]
Syrup
Strength: Concentrated decoction (approximately 1:5 root to final syrup volume) with honey or blackstrap molasses
Prepare a concentrated decoction by simmering 50-100 g of dried Yellow Dock root in 500 mL water for 30-45 minutes. Strain and reduce the liquid by gentle simmering to approximately 250 mL. While warm, dissolve an equal volume (250 mL) of raw honey or blackstrap molasses (molasses is traditional for anemia formulas as it contributes additional iron). Stir thoroughly until fully dissolved. Optionally add 10-20 mL of brandy as a preservative. Store refrigerated in glass bottles.
1-2 tablespoons (15-30 mL) two to three times daily
Two to three times daily, before meals
6-12 weeks for iron-deficiency anemia; 4-8 weeks as a general spring tonic
1-2 teaspoons (5-10 mL) twice daily for children 6-12 (the syrup form is more suitable for pediatric use than tincture)
The Yellow Dock syrup or 'iron tonic' is one of the classic preparations of Western herbalism for iron-deficiency anemia. When prepared with blackstrap molasses (which itself contains approximately 3.5 mg iron per tablespoon), the iron content is compounded. This preparation is traditionally taken as a spring tonic or throughout pregnancy (under practitioner guidance) to maintain iron levels. The syrup is more palatable than the raw decoction and is the most suitable preparation for children. Some commercial 'iron tonic' syrups combine Yellow Dock with nettle, dandelion, and other nutritive herbs.
Poultice
Strength: Fresh grated root or dried powdered root mixed to paste consistency
For a fresh root poultice: grate or mash fresh Yellow Dock root and apply directly to the affected area, covering with a clean cloth. For a dried root poultice: simmer 2-3 tablespoons of powdered dried root in a small amount of water to form a thick paste, allow to cool to a comfortable temperature, apply to the skin, and cover with gauze or clean cloth. Leave in place for 30-60 minutes. For a leaf poultice: crush fresh dock leaves and apply directly to nettle stings, insect bites, or minor skin irritation.
Apply topically to affected area 2-3 times daily
2-3 times daily or as needed for topical conditions
Until resolution of acute symptoms (nettle stings, insect bites) or for 1-2 weeks for chronic skin conditions
Suitable for external use in children; same application
The poultice is the most direct topical preparation and draws on both the astringent tannin and antimicrobial anthraquinone actions. Particularly indicated for ringworm, boils, and localized eczema. The fresh leaf poultice for nettle stings is one of the most widespread folk remedies in the British Isles and Europe -- dock (Rumex) species frequently grow alongside nettles (Urtica dioica), leading to the traditional rhyme 'Nettle in, dock out, dock rub nettle out.' The topical astringent action provides immediate soothing relief from the urticating histamine response.
Salve / Ointment
Strength: Approximately 1:5 dried root to olive oil (w/v), set with beeswax
Prepare an infused oil by gently warming 100 g of dried, chopped Yellow Dock root in 500 mL of olive oil over very low heat (or in a double boiler) for 2-4 hours, maintaining temperature below 60 degrees C. Strain through cheesecloth and press the marc. To the warm infused oil, add beeswax (approximately 30 g per 250 mL of infused oil) and stir until melted and well combined. Pour into clean tins or jars and allow to cool and solidify. The resulting ointment should be firm but spreadable.
Apply a thin layer to affected skin areas 2-3 times daily
2-3 times daily as needed
Up to 4 weeks for chronic skin conditions; discontinue if irritation occurs
Suitable for external use in children over 2 years
A Yellow Dock ointment or salve is a traditional preparation for chronic eczema, psoriasis, and minor wounds. The oil extraction captures lipophilic constituents (anthraquinones, chrysarobin) particularly relevant for skin activity, while the beeswax provides an occlusive, protective barrier. Some formulations add calendula (Calendula officinalis) infused oil for additional vulnerary and anti-inflammatory support. This preparation is especially useful for dry, scaly, or crusted eczema lesions. Avoid application to acutely inflamed, weeping, or broken skin (use the aqueous decoction as a wash instead for weeping lesions).
Safety & Interactions
Class 1
Can be safely consumed when used appropriately (AHPA Botanical Safety Handbook)
Contraindications
Yellow Dock contains oxalates (calcium oxalate and soluble oxalates) that can contribute to the formation of calcium oxalate kidney stones in susceptible individuals. While the oxalate content of the root at typical therapeutic doses is modest (substantially less than high-oxalate foods such as spinach or rhubarb leaf), individuals with a documented history of calcium oxalate nephrolithiasis should avoid Yellow Dock or use it only under practitioner supervision with adequate hydration and calcium intake to bind oxalates in the GI tract.
Individuals with documented allergy to Yellow Dock or related Polygonaceae species should not use this herb. Cross-reactivity with other Polygonaceae species (Rheum, Polygonum) is theoretically possible but not well documented.
As with all anthraquinone-containing herbs, Yellow Dock should not be used in the presence of intestinal obstruction or acute inflammatory intestinal conditions. Stimulant laxative action, even mild, could worsen these conditions. This is a standard contraindication for all anthraquinone laxatives per AHPA and WHO guidelines.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Digoxin (cardiac glycosides) (Cardiac glycosides) | theoretical | Theoretical concern based on the anthraquinone content. Chronic use of anthraquinone laxatives can cause potassium depletion (hypokalemia) through increased fecal electrolyte losses. Hypokalemia increases sensitivity to cardiac glycoside toxicity. However, the anthraquinone content of Yellow Dock is very low compared to senna or cascara, making clinically significant potassium depletion unlikely at standard doses. |
| Thiazide and loop diuretics (Diuretics) | theoretical | Additive potassium depletion. Both anthraquinone laxatives (via fecal potassium loss) and potassium-wasting diuretics reduce serum potassium. Combined use could theoretically increase hypokalemia risk. Again, this concern is far more relevant to stronger anthraquinone laxatives than to Yellow Dock. |
| Iron supplements and iron-containing medications (Iron preparations) | minor | Yellow Dock contains tannins that can bind iron and other minerals in the GI tract, potentially reducing absorption of concurrently administered iron supplements. Conversely, the oxalate content could also chelate iron. However, Yellow Dock also contains its own bioavailable iron and enhances iron absorption via cholagogue action, so the net effect is complex. |
| Medications with narrow therapeutic index (general consideration for absorption effects) (Various) | theoretical | The tannin content of Yellow Dock can theoretically reduce the absorption of concurrently administered oral medications by binding to drug molecules in the GI tract. This is a general concern with tannin-rich herbs rather than a Yellow Dock-specific interaction. |
Pregnancy & Lactation
Pregnancy
possibly unsafe
Lactation
insufficient data
Yellow Dock root contains anthraquinone glycosides, which as a class are generally contraindicated in pregnancy due to theoretical risk of stimulating uterine contractions (anthraquinones can stimulate smooth muscle including uterine muscle) and potential transfer to the fetus. While the anthraquinone content of Yellow Dock is considerably lower than that of senna or cascara, and traditional herbalists have historically used Yellow Dock during pregnancy (particularly as an iron tonic in the second and third trimesters), the precautionary principle advises against use in the first trimester and only cautious, practitioner-supervised use thereafter. The AHPA Botanical Safety Handbook does not specifically restrict Yellow Dock in pregnancy (it is Class 1, no restrictions), and some experienced herbal practitioners continue to recommend it for pregnancy-associated iron-deficiency anemia at standard doses in the second and third trimesters. During lactation, anthraquinones may theoretically pass into breast milk; however, clinical significance at Yellow Dock doses is uncertain. Use during breastfeeding should be under practitioner guidance.
Adverse Effects
References
Monograph Sources
- [1] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press, Rochester, Vermont (2003) . ISBN: 978-0892817498
- [2] British Herbal Medicine Association. British Herbal Pharmacopoeia (BHP): Rumex crispus monograph. British Herbal Medicine Association, Bournemouth (1983) . ISBN: 978-0903032070
- [3] Gardner Z, McGuffin M (editors). American Herbal Products Association's Botanical Safety Handbook, 2nd Edition. CRC Press, Boca Raton, FL (2013) . ISBN: 978-1466516946
- [4] Grieve M. A Modern Herbal: The Medicinal, Culinary, Cosmetic and Economic Properties, Cultivation and Folk-Lore of Herbs, Grasses, Fungi, Shrubs & Trees with Their Modern Scientific Uses. Jonathan Cape, London (reprinted Dover Publications, 1971) (1931)
Clinical Studies
- [5] Yildirim A, Mavi A, Kara AA. Determination of antioxidant and antimicrobial activities of Rumex crispus L. extracts. J Agric Food Chem (2001) ; 49 : 4083-4089 . DOI: 10.1021/jf0103572 . PMID: 11513714
- [6] Idris OA, Wintola OA, Afolayan AJ. Phytochemical and antioxidant activities of Rumex crispus L. in treatment of gastrointestinal helminths in Eastern Cape Province, South Africa. Asian Pac J Trop Biomed (2017) ; 7 : 1071-1078 . DOI: 10.1016/j.apjtb.2017.10.008
- [7] Copland A, Nahar L, Tober CT, Hamilton V, Sherazi S, Mayasinghe UG, Sarker SD. Antibacterial and free radical scavenging activity of the seeds of Agrimonia eupatoria. Fitoterapia (2003) ; 74 : 133-135 . DOI: 10.1016/S0367-326X(02)00287-3 . PMID: 12628411
- [8] Dong X, Fu J, Yin X, Cao S, Li X, Lin L, Ni J. Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics. Phytother Res (2016) ; 30 : 1207-1218 . DOI: 10.1002/ptr.5631 . PMID: 27188216
Traditional Texts
- [9] Felter HW, Lloyd JU. King's American Dispensatory, 18th Edition: Rumex. Ohio Valley Company, Cincinnati (1898)
- [10] Priest AW, Priest LR. Herbal Medication: A Clinical and Dispensary Handbook. L.N. Fowler & Co., London (1982) . ISBN: 978-0852430767
- [11] Moerman DE. Native American Ethnobotany. Timber Press, Portland, Oregon (1998) . ISBN: 978-0881924534
Pharmacopeias & Reviews
- [12] British Herbal Medicine Association. British Herbal Pharmacopoeia 1983: Rumex crispus. British Herbal Medicine Association, Bournemouth, UK (1983)
Last updated: 2026-03-02 | Status: review
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.